Phantom ForcesPhantom Forces🃏All Alomomola cards
Ask about Alomomola
Alomomola #22 Pokémon card from Phantom Forces

Alomomola 22/119

Phantom Forces

Find this card on eBay

Affiliate link · we may earn commission

Alomomola #22 from Phantom Forces currently trades at $0.50 raw, with PSA 10 copies reaching $35.31 — a 70.6x grade premium.
Current Prices (USD)
Ungraded
$0.50
PSA 7
$4.41
PSA 8
$4.41
PSA 9
$12.67
PSA 10
$35.31
ACE 10
BGS 10 Black
$230.00
CGC 10 Pristine
$38.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Alomomola 22/119 from Phantom Forces has a current raw market value of $0.50.

Current raw value
$0.50
PSA 9 value
$12.67
PSA 10 value
$35.31
PSA 10 premium vs raw
70.6× raw
View all cards from Phantom Forces
Collector Intel
70.6x
Raw → PSA 10
High-risk grade
25.3x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 71x the raw price. The expected value accounts for the realistic probability.
$1
Buy Raw
~$25
Grading Fee
PSA Standard
$35
PSA 10 Value
+$10
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$1325.3x raw
PSA 10$3570.6x raw

Frequently asked questions

How much is Alomomola #22 from Phantom Forces worth?+
Alomomola #22 from Phantom Forces is currently worth Raw: $0.50, PSA 9: $12.67, PSA 10: $35.31 based on recent sold listings. Prices update daily from real eBay sales.
Is Alomomola #22 worth grading?+
The PSA 10 price of $35.31 is 70.6× the raw price of $0.50. After a ~$25 grading fee, a PSA 10 result would net approximately $34.81 — assuming the card grades a 10.
Where do PokePrices Alomomola #22 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.